Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

ÀڱðæºÎ¾ÏÀÇ ¹æ»ç¼± Ä¡·á ÈÄ ±Þ¼ºÀå°ü ÇÕº´Áõ Early Bowel Complications Following Radiotherapy of Uterine Cervix Carcinoma

´ëÇѹæ»ç¼±Á¾¾çÇÐȸÁö 1999³â 17±Ç 2È£ p.129 ~ 135
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿øµ¿/Won Dong Kim

Abstract

¸ñ Àû : ÀúÀÚ´Â ÀڱðæºÎ¾ÏÀ¸·Î ¿ÜºÎ ¹æ»ç¼± Ä¡·á¿Í °í¼±·® °­³»Ä¡·á¸¦ ¹ÞÀº ½Å¼± Áõ·Ê¿¡
¼­ ±Þ¼ºÀå°ü ¹æ»ç¼± ÇÕº´Áõ¿¡ ´ëÇÏ¿© °üÂûÇÏ°í ÀÌ¿Í ¿¬°üµÈ ¿©·¯ ÀÎÀÚµéÀ» ¹àÈ÷°íÀÚ ÇÑ´Ù.
¸ñÀû ¹× ¹æ¹ý : 1994³â 4¿ùºÎÅÍ 1598³â 12¿ù±îÁö ÃæºÏ´ëÇб³º´¿ø Ä¡·á ¹æ»ç¼±°ú¿¡¼­ ±ÙÄ¡
Àû ¹æ»ç¼± Ä¡·á¸¦ ½ÃÇàÇÑ 66·Ê¸¦ ´ë»óÀ¸·Î ±Þ¼ºÀå°ü ÇÕº´Áõ¿¡ ´ëÇÏ¿© ÈÄÇâÀû ºÐ¼®À» ½Ç½ÃÇÏ
¿´´Ù. ¸ðµç ȯÀÚ´Â º»°úÀÇ Ä¡·á ¿øÄ¢¿¡ µû¶ó 4§¯ ¹Ì¸¸ÀÇ, º´±â ¥°B1 ¿Í ¥±A °æ¿ì´Â 41.4§í
ÀÇ Ã¼¿ÜÁ¶»ç ÈÄ 30§íÀÇ °­³»Á¶»ç¸¦ AÁ¡ ±âÁØÀ¸·Î ½Ç½ÃÇÏ¿´À¸¸ç ±× ÀÌ¿Ü¿¡´Â 50.4§íÀÇ Ã¼¿Ü
Á¶»ç ÈÄ 24§íÀÇ °­³»Á¶»ç¸¦ ½Ç½ÃÇÏ¿´´Ù. ±Þ¼ºÀå°ü ÇÕº´ÁõÀÇ ±âÁØÀ¸·Î´Â EORTC/RTOG
morbidity criteria¸¦ ÀÌ¿ëÇÏ¿´À¸¸ç ÀÌ ±âÁØ¿¡ µû¶ó Ä¡·á ù³¯ºÎÅÍ 90ÀϱîÁö ¹ß»ýÇÑ ÇÕº´Áõ
À» ±Þ¼ºÀ¸·Î °£ÁÖÇÏ¿´´Ù. ±Þ¼º ÇÕº´ÁõÀÇ ºóµµ ¹× °æÁßÀ» ÆľÇÇÏ¿´À¸¸ç ±Þ¼ºÀå°ü ÇÕº´Áõ°ú
¿¬°üµÈ ¿©·¯ Ä¡·áÀü ÀÓ»ó ¿äÀÎÀ» ¹àÈ÷±â À§ÇÏ¿© ´Üº¯¼ö ºÐ¼®°ú ´Ùº¯¼ö ºÐ¼®À» ½Ç½ÃÇÏ¿´´Ù.
°á °ú : ÃÑ 66 ¸íÀÇ È¯ÀÚ Áß 30¸í(46%)¿¡¼­ ±Þ¼ºÀå°ü ÇÕº´ÁõÀÌ ¹ß»ýÇÏ¿´°í ±× Áß 25¸í
(38%)Àº grade 1, 2ÀÇ °æ¹ÌÇÑ ÇÕº´ÁõÀ̾úÀ¸¸ç 4¸í(6%)Àº grade 3, 1¸í(2%)Àº grade 4ÀÇ Áß
Áõ ÇÕº´ÁõÀ̾ú´Ù. °ÅÀÇ ¸ðµç ÇÕº´ÁõÀº ¹æ»ç¼± Ä¡·á ½ÃÀÛ 3ÁÖ ÈÄ¿¡ ¹ß»ýÇÏ¿´À¸¸ç ´©Àû ¹ß»ý
ºóµµ´Â 10ÁÖ¿¡ 41%¿´´Ù. °í¿¬·É°ú º¹ºÎ ¹× °ñ¹ÝºÎ ¼ö¼ú °ú°Å·ÂÀÌ ±Þ¼ºÀå°ü ÇÕº´Áõ°ú À¯°ü
ÇÑ ÀÎÀÚ¿´À¸¸ç 3¸íÀÇ È¯ÀÚ¿¡¼­´Â ±Þ¼ºÀå°ü ÇÕº´ÁõÀ¸·Î Àüü Ä¡·á±â°£ÀÌ ¾à 2ÁÖ Áõ°¡ÇÏ¿´À¸
¸ç °á13¸í ¸ðµÎ °ñ¹Ý ³» Àç¹ßÀ» °æÇèÇÏ¿´´Ù.
°á ·Ð : 46%ÀÇ È¯ÀÚ°¡ ±Þ¼ºÀå°ü ÇÕº´ÁõÀ» °æÇèÇÏ¿´À¸¸ç ´ëºÎºÐÀº °æ¹ÌÇÏ¿© ÀÓ»óÀûÀÎ ¹®
Á¦¸¦ ¾ß±âÇÏÁö ¾Ê¾Ò´Ù. ´Ù¸¸ °í¿¬·É ¹× ¼ö¼ú º´·ÂÀÌ Àִ ȯÀÚ¿¡¼­´Â ±Þ¼ºÀå°ü ÇÕº´ÁõÀ¸·Î
ÀÎÇÏ¿© ¹æ»ç¼± Ä¡·á¿¡ ´ëÇÑ È¯ÀÚÀÇ ¼øÀÀµµ(compliance)°¡ ³·¾ÆÁú ¼ö ÀÖÀ¸¹Ç·Î º¸´Ù ´õ Àû±Ø
ÀûÀÎ ÁÖÀÇ°¡ ÇÊ¿äÇÏ´Ù°í ÇÏ°Ú´Ù.

Purpose : This study evaluated carry bowel complications in cervix cancer patients,
following external radiotherapy (ERT) and high dose rate intracavitary radiation (HDR
ICR). Factors affecting the risk of developing early bowel complications and its incidence
are analyzed and discussed.
Materials and Methods : The study is the retrospective review of 66 patients who
received radiotherapy at Chungbuk National University Hospital from April 1994 to
December 1998. The patients underwent 41.4 or 50.4 §í ERT according to FIGO stage
and tumor size, then A point dose was boosted to 71.4 or 74.4 §í using a remotely
controlled afterloading Buchler HDR ICR The EORTC/RTOG morbidity criteria ware
used to grade early bowel complications, which are valid from day 1, the commencement
of therapy, through day 90. The actuarial incidence, severity of complications were
investigated and clinical pretreatment factors relevant to complications were found
through univariate (Wilcoxon) and multivariate (Cox proportional hazard model) analysis.
Results : Of the 66 patients, 30 patients (46%) developed early bowel complications; 25
patients (38%) with grade 1 or 2, 4 patients (6%) with grade 3 and 1 patient (2%) with
grade 4. The complications usually began to occur 3 weeks after the commencement of
radiotherapy. The actuarial incidence of early bowel complications was 41% at 10 weeks.
The early bowel complications were associated significantly with an old age and a
history of previous abdomino-pelvic surgery. All three patients who had a protracted
overall treatment time (about 2 weeks) due to severe bowel complication, suffered from
pelvic recurrences.
Conclusion : Forty six percent of patients experienced early bowel complications, most
of which were grade 1 or 2 and relieved spontaneously or by medication. The patients
with an old age or a previous surgery have a high probability of early complications
and they may be less compliant with planned radiotherapy. So more careful precaution
is necessary for these patients.

Å°¿öµå

±Þ¼ºÀå°ü ÇÕº´Áõ@¹æ»ç¼±Ä¡·á@ÀڱðæºÎ¾Ï; Early bowel complications; Radiotherapy; Cervix cancer;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS